With a new and rapid technology to measure biomarkers, carefully benchmarked against current gold standards, we seek to drive a disruptive shift in capability, access, and precision of biomarker data for screening and diagnostics. We aim to make Fragment synonymous with rapid biosensing.
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2023 (2 years)
Address:
MELBOURNE, AU
LOW
spending power
